Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPS3A pseudogene 39 (RPS3AP39) is a processed pseudogene located on human chromosome 11 (chr11:3549745-3550519, hg38)[7]. It is one of many pseudogenes derived from the parent gene, ribosomal protein S3A (RPS3A), which is involved in protein synthesis as a component of the 40S ribosomal subunit[3][5][6][8][10]. Unlike the functional RPS3A gene, RPS3AP39 does not encode a functional protein and has no established biological activity, relevance to disease, or therapeutic targeting in current biomedical research[6][8]. Pseudogenes like RPS3AP39 are commonly found throughout the human genome and typically serve as evolutionary remnants or may participate in gene regulation in rare cases, but no such function is reported for RPS3AP39[6][8][10]. RPS3A (not RPS3AP39) is the parent ribosomal protein with established roles in protein synthesis and disease association, including cancer and neurodegenerative conditions[2][5][9]. Pseudogenes of RPS3A, such as RPS3AP39, are molecular fossils and not direct drug targets or disease-related biomarkers[6][8][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S3a pseudogene 39 (RPS3AP39).